Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 19, 2018

DrugPatentWatch Database Preview

Breckenridge Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for BRECKENRIDGE PHARM, and what generic and branded alternatives to BRECKENRIDGE PHARM drugs are available?

BRECKENRIDGE PHARM has thirty-two approved drugs.

Summary for Breckenridge Pharm

US Patents:	0
Tradenames:	27
Ingredients:	27
NDAs:	32
Patent Litigation for Breckenridge Pharm:	See patent lawsuits for Breckenridge Pharm
PTAB Cases with Breckenridge Pharm as petitioner:	See PTAB cases with Breckenridge Pharm as petitioner

Drugs and US Patents for Breckenridge Pharm

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Breckenridge Pharm	PIOGLITAZONE HYDROCHLORIDE	pioglitazone hydrochloride	TABLET;ORAL	078472-002	Feb 13, 2013	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Breckenridge Pharm	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	091450-002	Oct 8, 2010	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Breckenridge Pharm	METHSCOPOLAMINE BROMIDE	methscopolamine bromide	TABLET;ORAL	040642-002	Dec 6, 2011	AA	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Breckenridge Pharm	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	091450-004	Oct 8, 2010	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Breckenridge Pharm	PIOGLITAZONE HYDROCHLORIDE	pioglitazone hydrochloride	TABLET;ORAL	078472-001	Feb 13, 2013	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Breckenridge Pharm	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET, CHEWABLE;ORAL	204954-003	Jan 26, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Paragraph IV (Patent) Challenges for BRECKENRIDGE PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Breckenridge Pharm

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck

Dow

Deloitte

Citi

Fuji

QuintilesIMS

Moodys

Medtronic

Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.